represented 10.6% YOY while non-durable goods, in which high proportion of low to medium-income household expenditure, growth only 0.0% YOY since partly owing to household debt that was still elevated at 78% to
. Rising part of THB 14.1 or 26.32% was brought by additional staff and rental expenses for new branches. The proportion of selling expenses to total revenue for Q2/ 2018 and Q2/ 2017 were 32.35% and 30.42
increase the proportion of high gross margin products. In addition, the acquisition of assets mentioned above is the acquisition of assets according to the Notification of the Capital Market Supervisory
shareholders of the Company in proportion to their shareholdings (Right Offering) with the following details (a) offered the ratio of 3.90existing shares to 1 newly issued shares at the offering price of THB 1
NTA of the Registered Company = Cannot be calculated due to Unimit Engineering (Myanmar) Co. Ltd not yet run 2. NET PROFIT METHOD Net profit method = (Net operating income of invest company x proportion
same proportion in the investment value of secure loan and unsecure loan. The Company selection to purchase non-performing loans mainly considered the return on investment to create profits to
slight decline in calcium carbonate product group sales, especially in Q1. (2.2) Cost of Goods Sold and Gross Profit Margin (% of revenue excluding other income) In Q2/2017, the proportion of cost of goods
selling medical equipment 60.65 73.92 Administrative expenses 109.64 105.99 Finance costs 22.86 24.24 Finance costs (net) 20.87 21.71 Proportion of cost of medical treatment / revenue of medical treatment
590.59 553.11 Cost of selling medical equipment 65.30 57.70 Administrative expenses 112.97 109.49 Finance costs 19.32 24.93 Finance costs (net) 16.90 22.87 Proportion of cost of medical treatment / revenue
Company shall subscribe the newly issued share in proportion of 108,022 shares and the newly issued share in portion of the unsubscribed shares of other shareholders of 40,604 shares. As subscription of